Multiple Choice
An elderly patient is diagnosed with aggressive non-Hodgkin's lymphoma. The tumor cells are shown to stain strongly for the CD20 marker. Which of the following biologic agents can be added to this patient's chemotherapy regimen to help improve the treatment response?
A) Infliximab
B) Rituximab
C) Interleukin-2
D) Imatinib
E) Abciximab
Correct Answer:
Verified
Correct Answer:
Verified
Q164: A boy is delivered via spontaneous vaginal
Q165: A 52-year-old man comes to the office
Q166: A 58-year-old airline captain comes to the
Q167: A 75-year-old woman is brought to the
Q168: A 72-year-old woman is brought to the
Q170: A 23-year-old man is evaluated for excessive
Q171: A 70-year-old man develops progressive fatigue and
Q172: A 60-year-old man with known coronary artery
Q173: A 66-year-old man comes to the office
Q174: A 43-year-old man is hospitalized due to